Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by ß-catenin stabilization

Emanuela Mrak, Francesca Guidobono, Gianluigi Moro, Gianfranco Fraschini, Alessandro Rubinacci, Isabella Villa

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Transgenic mice over-expressing calcitonin gene-related peptide (CGRP) in osteoblasts have increased bone density due to increased bone formation, thus suggesting that CGRP plays a role in bone metabolism. In this study we determined the relationship between CGRP, the canonical Wnt signaling and apoptosis in human osteoblasts (hOBs) in consideration of the well-documented involvement of this pathway in bone cells. Primary cultures of hOBs were treated with CGRP 10 -8-M. Levels of ß-catenin, which is the cytoplasmic protein mediator of canonical Wnt signaling, and mRNA were determined. CGRP increases both the expression and the levels of cytoplasmic ß-catenin by binding to its receptor, as this effect is blocked by the antagonist CGRP 8-37. This facilitatory action on ß-catenin appears to be mediated by the inhibition of the enzyme GSK-3ß via protein kinase A (PKA) activation. GSK-3ß is a glycogen synthase kinase that, by phosphorylating ß-catenin, promotes its degradation by the proteosomal machinery. Moreover, the peptide is able to inhibit hOBs apoptosis stimulated by dexamethasone or by serum deprivation, possibly through the accumulation of ß-catenin, since the inhibitor of PKA activity H89 partially prevents the antiapoptotic effect of the peptide. In conclusion CGRP, released by nerve fibers, exerts its anabolic action on bone cells by stimulating canonical Wnt signaling and by inhibiting hOBs apoptosis, thus favoring local bone regeneration.

Original languageEnglish
Pages (from-to)701-708
Number of pages8
JournalJournal of Cellular Physiology
Volume225
Issue number3
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Catenins
Calcitonin Gene-Related Peptide
Osteoblasts
Bone
Stabilization
Apoptosis
Glycogen Synthase Kinase 3
Cyclic AMP-Dependent Protein Kinases
Bone and Bones
Glycogen Synthase Kinases
Peptides
Bone Regeneration
Nerve Fibers
Cell culture
Metabolism
Osteogenesis
Bone Density
Dexamethasone
Transgenic Mice
Machinery

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by ß-catenin stabilization. / Mrak, Emanuela; Guidobono, Francesca; Moro, Gianluigi; Fraschini, Gianfranco; Rubinacci, Alessandro; Villa, Isabella.

In: Journal of Cellular Physiology, Vol. 225, No. 3, 12.2010, p. 701-708.

Research output: Contribution to journalArticle

Mrak, Emanuela ; Guidobono, Francesca ; Moro, Gianluigi ; Fraschini, Gianfranco ; Rubinacci, Alessandro ; Villa, Isabella. / Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by ß-catenin stabilization. In: Journal of Cellular Physiology. 2010 ; Vol. 225, No. 3. pp. 701-708.
@article{9d7141569f6548fb860e53b34ac89887,
title = "Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by {\ss}-catenin stabilization",
abstract = "Transgenic mice over-expressing calcitonin gene-related peptide (CGRP) in osteoblasts have increased bone density due to increased bone formation, thus suggesting that CGRP plays a role in bone metabolism. In this study we determined the relationship between CGRP, the canonical Wnt signaling and apoptosis in human osteoblasts (hOBs) in consideration of the well-documented involvement of this pathway in bone cells. Primary cultures of hOBs were treated with CGRP 10 -8-M. Levels of {\ss}-catenin, which is the cytoplasmic protein mediator of canonical Wnt signaling, and mRNA were determined. CGRP increases both the expression and the levels of cytoplasmic {\ss}-catenin by binding to its receptor, as this effect is blocked by the antagonist CGRP 8-37. This facilitatory action on {\ss}-catenin appears to be mediated by the inhibition of the enzyme GSK-3{\ss} via protein kinase A (PKA) activation. GSK-3{\ss} is a glycogen synthase kinase that, by phosphorylating {\ss}-catenin, promotes its degradation by the proteosomal machinery. Moreover, the peptide is able to inhibit hOBs apoptosis stimulated by dexamethasone or by serum deprivation, possibly through the accumulation of {\ss}-catenin, since the inhibitor of PKA activity H89 partially prevents the antiapoptotic effect of the peptide. In conclusion CGRP, released by nerve fibers, exerts its anabolic action on bone cells by stimulating canonical Wnt signaling and by inhibiting hOBs apoptosis, thus favoring local bone regeneration.",
author = "Emanuela Mrak and Francesca Guidobono and Gianluigi Moro and Gianfranco Fraschini and Alessandro Rubinacci and Isabella Villa",
year = "2010",
month = "12",
doi = "10.1002/jcp.22266",
language = "English",
volume = "225",
pages = "701--708",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by ß-catenin stabilization

AU - Mrak, Emanuela

AU - Guidobono, Francesca

AU - Moro, Gianluigi

AU - Fraschini, Gianfranco

AU - Rubinacci, Alessandro

AU - Villa, Isabella

PY - 2010/12

Y1 - 2010/12

N2 - Transgenic mice over-expressing calcitonin gene-related peptide (CGRP) in osteoblasts have increased bone density due to increased bone formation, thus suggesting that CGRP plays a role in bone metabolism. In this study we determined the relationship between CGRP, the canonical Wnt signaling and apoptosis in human osteoblasts (hOBs) in consideration of the well-documented involvement of this pathway in bone cells. Primary cultures of hOBs were treated with CGRP 10 -8-M. Levels of ß-catenin, which is the cytoplasmic protein mediator of canonical Wnt signaling, and mRNA were determined. CGRP increases both the expression and the levels of cytoplasmic ß-catenin by binding to its receptor, as this effect is blocked by the antagonist CGRP 8-37. This facilitatory action on ß-catenin appears to be mediated by the inhibition of the enzyme GSK-3ß via protein kinase A (PKA) activation. GSK-3ß is a glycogen synthase kinase that, by phosphorylating ß-catenin, promotes its degradation by the proteosomal machinery. Moreover, the peptide is able to inhibit hOBs apoptosis stimulated by dexamethasone or by serum deprivation, possibly through the accumulation of ß-catenin, since the inhibitor of PKA activity H89 partially prevents the antiapoptotic effect of the peptide. In conclusion CGRP, released by nerve fibers, exerts its anabolic action on bone cells by stimulating canonical Wnt signaling and by inhibiting hOBs apoptosis, thus favoring local bone regeneration.

AB - Transgenic mice over-expressing calcitonin gene-related peptide (CGRP) in osteoblasts have increased bone density due to increased bone formation, thus suggesting that CGRP plays a role in bone metabolism. In this study we determined the relationship between CGRP, the canonical Wnt signaling and apoptosis in human osteoblasts (hOBs) in consideration of the well-documented involvement of this pathway in bone cells. Primary cultures of hOBs were treated with CGRP 10 -8-M. Levels of ß-catenin, which is the cytoplasmic protein mediator of canonical Wnt signaling, and mRNA were determined. CGRP increases both the expression and the levels of cytoplasmic ß-catenin by binding to its receptor, as this effect is blocked by the antagonist CGRP 8-37. This facilitatory action on ß-catenin appears to be mediated by the inhibition of the enzyme GSK-3ß via protein kinase A (PKA) activation. GSK-3ß is a glycogen synthase kinase that, by phosphorylating ß-catenin, promotes its degradation by the proteosomal machinery. Moreover, the peptide is able to inhibit hOBs apoptosis stimulated by dexamethasone or by serum deprivation, possibly through the accumulation of ß-catenin, since the inhibitor of PKA activity H89 partially prevents the antiapoptotic effect of the peptide. In conclusion CGRP, released by nerve fibers, exerts its anabolic action on bone cells by stimulating canonical Wnt signaling and by inhibiting hOBs apoptosis, thus favoring local bone regeneration.

UR - http://www.scopus.com/inward/record.url?scp=77957838269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957838269&partnerID=8YFLogxK

U2 - 10.1002/jcp.22266

DO - 10.1002/jcp.22266

M3 - Article

C2 - 20533307

AN - SCOPUS:77957838269

VL - 225

SP - 701

EP - 708

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 3

ER -